These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16791014

  • 1. Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.
    Winston A, Back D, Fletcher C, Robinson L, Unsworth J, Tolowinska I, Schutz M, Pozniak AL, Gazzard B, Boffito M.
    AIDS; 2006 Jun 26; 20(10):1401-6. PubMed ID: 16791014
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects.
    Singh K, Dickinson L, Chaikan A, Back D, Fletcher C, Pozniak A, Moyle G, Nelson M, Gazzard B, Herath D, Boffito M.
    Clin Pharmacol Ther; 2008 Jun 26; 83(6):867-72. PubMed ID: 17898705
    [Abstract] [Full Text] [Related]

  • 3. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B, Riek M, Holmes B, Grange S.
    Antivir Ther; 2005 Jun 26; 10(7):803-10. PubMed ID: 16312177
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir.
    Hsu A, Granneman GR, Cao G, Carothers L, el-Shourbagy T, Baroldi P, Erdman K, Brown F, Sun E, Leonard JM.
    Clin Pharmacol Ther; 1998 Apr 26; 63(4):453-64. PubMed ID: 9585800
    [Abstract] [Full Text] [Related]

  • 6. Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100 mg once daily versus twice daily.
    Boffito M, Maitland D, Dickinson L, Back D, Hill A, Fletcher C, Moyle G, Nelson M, Gazzard B, Pozniak A.
    J Antimicrob Chemother; 2005 Apr 26; 55(4):542-5. PubMed ID: 15722388
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.
    von Hentig N, Nisius G, Lennemann T, Khaykin P, Stephan C, Babacan E, Staszewski S, Kurowski M, Harder S, Haberl A.
    Antivir Ther; 2008 Apr 26; 13(8):1039-46. PubMed ID: 19195329
    [Abstract] [Full Text] [Related]

  • 8. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN, Falcon RW.
    Pharmacotherapy; 2006 Aug 26; 26(8):1060-8. PubMed ID: 16863482
    [Abstract] [Full Text] [Related]

  • 9. Single daily doses of saquinavir achieve HIV-inhibitory concentrations when combined with baby-dose ritonavir.
    Kurowski M, Müller M, Donath F, Mrozikiewicz M, Möcklinghoff C.
    Eur J Med Res; 1999 Mar 26; 4(3):101-4. PubMed ID: 10085276
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E, Azuaje C, Lopez RM, Domingo P, Curran A, Feijoo M, Pou L, Sánchez P, Sambeat MA, Colomer J, Lopez-Colomes JL, Crespo M, Falcó V, Ocaña I, Pahissa A.
    J Antimicrob Chemother; 2007 Apr 26; 59(4):690-7. PubMed ID: 17307771
    [Abstract] [Full Text] [Related]

  • 11. Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration.
    Stocker H, Herzmann C, Breske A, Kruse G, Berger M, Schulbin H, Hill A, Steinmüller J, Becker M, Arastéh K, Kurowski M.
    J Antimicrob Chemother; 2007 Mar 26; 59(3):560-4. PubMed ID: 17255144
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects.
    Boffito M, Back D, Stainsby-Tron M, Hill A, Di Perri G, Moyle G, Nelson M, Tomkins J, Gazzard B, Pozniak A.
    Br J Clin Pharmacol; 2005 Jan 26; 59(1):38-42. PubMed ID: 15606438
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
    Sekar VJ, Lefebvre E, De Paepe E, De Marez T, De Pauw M, Parys W, Hoetelmans RM.
    Antimicrob Agents Chemother; 2007 Mar 26; 51(3):958-61. PubMed ID: 17210768
    [Abstract] [Full Text] [Related]

  • 14. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
    van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Lange JM, Beijnen JH, Hoetelmans RM.
    AIDS; 2000 Jun 16; 14(9):F103-10. PubMed ID: 10894270
    [Abstract] [Full Text] [Related]

  • 15. Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients.
    Ruxrungtham K, Boyd M, Bellibas SE, Zhang X, Dorr A, Kolis S, Kinchelow T, Buss N, Patel IH.
    J Clin Pharmacol; 2004 Jul 16; 44(7):793-803. PubMed ID: 15199084
    [Abstract] [Full Text] [Related]

  • 16. Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
    Jamois C, Smith P, Morrison R, Riek M, Patel A, Schmitt C, Morcos PN, Zhang X.
    Addict Biol; 2009 Jul 16; 14(3):321-7. PubMed ID: 19523046
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women.
    Martinez-Rebollar M, Lonca M, Perez I, Soy D, Brunet M, Martin R, Coll O, Hernandez S, Laguno M, Milinkovic A, Larrousse M, Calvo M, Blanco JL, Martínez E, Gatell JM, Mallolas J.
    Ther Drug Monit; 2011 Dec 16; 33(6):772-7. PubMed ID: 22105596
    [Abstract] [Full Text] [Related]

  • 18. The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone.
    Shelton MJ, Cloen D, DiFrancesco R, Berenson CS, Esch A, de Caprariis PJ, Palic B, Schur JL, Buggé CJ, Ljungqvist A, Espinosa O, Hewitt RG.
    J Clin Pharmacol; 2004 Mar 16; 44(3):293-304. PubMed ID: 14973306
    [Abstract] [Full Text] [Related]

  • 19. Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.
    Autar RS, Wit FW, Sankote J, Sutthichom D, Kimenai E, Hassink E, Hill A, Cooper DA, Phanuphak P, Lange JM, Burger DM, Ruxrungtham K.
    AIDS; 2007 Jul 31; 21(12):1535-9. PubMed ID: 17630547
    [Abstract] [Full Text] [Related]

  • 20. A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus.
    Gallicano K, Khaliq Y, Carignan G, Tseng A, Walmsley S, Cameron DW.
    Clin Pharmacol Ther; 2001 Aug 31; 70(2):149-58. PubMed ID: 11503009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.